Interplay between nanomedicine and protein corona

Min Yang1, Ercan Wu, Wenjing Tang

  • 1Department of Pharmacology, School of Basic Medical Sciences & Center of Medical Research and Innovation, Shanghai Pudong Hospital & State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200032, P. R. China. cyzhan@fudan.edu.cn.

Summary

Nanomedicine offers great potential, but its clinical use is limited by the protein corona (PC). Understanding how nanomedicine properties and biological environments shape the PC is key to improving safety and efficacy.